HeyL regulates the number of TrkC neurons in dorsal root ganglia  by Mukhopadhyay, Abhishek et al.
Developmental Biology 334 (2009) 142–151
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyHeyL regulates the number of TrkC neurons in dorsal root ganglia
Abhishek Mukhopadhyay ⁎, Jennifer Jarrett, Timothy Chlon, John A. Kessler
Department of Neurology, Northwestern University's Feinberg School of Medicine, Chicago, IL 60611, USA⁎ Corresponding author. Fax: +1 312 503 0872.
E-mail address: mukho@md.northwestern.edu (A. M
0012-1606/$ – see front matter © 2009 Elsevier Inc. Al
doi:10.1016/j.ydbio.2009.07.018a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 2 April 2009
Revised 6 July 2009
Accepted 10 July 2009
Available online 22 July 2009
Keywords:
Dorsal root ganglion
TrkC
HeyL
Hey1
DifferentiationThe basic-helix-loop-helix transcription factor HeyL is expressed at high levels by neural crest progenitor
cells (NCPs) that give rise to neurons and glia in dorsal root ganglia (DRG). Since HeyL expression was
observed in these NCPs during the period of neurogenesis, we generated HeyL null mutants to help examine
the factor's role in ganglion neuronal speciﬁcation. Homozygous null mutation of HeyL reduced the number
of TrkC+ neurons in DRG at birth including the subpopulation that expresses the ETS transcription factor
ER81. Conversely, null mutation of the Hey paralog, Hey1, increased the number of TrkC+ neurons. Null
mutation of HeyL increased expression of the Hey paralogs Hey1 and Hey2, suggesting that HeyL normally
inhibits their expression. Double null mutation of both Hey1 and HeyL rescued TrkC+ neuron numbers to
control levels. Thus, the balance between HeyL and Hey1 expression regulates the differentiation of a
subpopulation of TrkC+ neurons in the DRG.
© 2009 Elsevier Inc. All rights reserved.Introduction
The basic-helix-loop-helix (bHLH) transcription factors, hairy and
Enhancer of split are transcriptional repressors in Drosophila that
mediate some of the effects of the Notch signaling pathway on neural
stem cell differentiation (Klambt et al., 1989; Lecourtois and
Schweisguth, 1995). Related proteins in mammals include the Hes
and Hey families of repressors (Akazawa et al., 1992; Leimeister et al.,
1999; Nakagawa et al., 1999; Sasai et al., 1992; Thomas and Rathjen,
1992). The Hes family has seven members, Hes1–7, of which Hes1,
Hes3, Hes5 and Hes6 are expressed in the developing nervous system
(Akazawa et al., 1992; Sakagami et al., 1994; Sasai et al., 1992). In the
mammalian central nervous system (CNS) Hes1 and Hes5 act as
repressors of proneuronal genes like Mash1 thereby preventing
differentiation (Akazawa et al., 1995; Castella et al., 1999; de la
Pompa et al., 1997; Ishibashi et al., 1995, 1994; Jarriault et al., 1995;
Nakamura et al., 2000). Hes3 has two isoforms, one of which has
repressor activity similar to Hes1 while the other lacks repressor
activity (Hirata et al., 2000, 2001). Hes6 represses Hes1 activity and
conversely promotes neuronal differentiation (Bae et al., 2000;
Gratton et al., 2003; Koyano-Nakagawa et al., 2000). Thus, different
Hes proteins play contrasting roles in neural differentiation.
Hey1, Hey2 and HeyL constitute the mammalian Hey (also known
as CHF, Hesr, Herp, and Hrt) family that, like the Hes proteins, act
downstream of the Notch signaling pathway (Iso et al., 2001;
Leimeister et al., 1999; Nakagawa et al., 2000, 1999; Steidl et al.,
2000). TheHey genes play an important role in the development of the
cardiovascular system and loss of Hey function causes defects inukhopadhyay).
l rights reserved.vascular speciﬁcation, septation and valve formation (Donovan et al.,
2002; Fischer et al., 2004, 2007; Gessler et al., 2002; Kokubo et al.,
2005, 2004, 2007; Sakata et al., 2002; Xin et al., 2007). In the
developing brain, overexpression of Hey1 and Hey2 prevents neural
precursors from differentiating during the neurogenic period and
causes glial differentiationbyantagonizingneuronal bHLH factors later
in development (Sakamoto et al., 2003). HeyL overexpression in the
developing retina increases rod differentiation whereas Hey2
increases gliogenesis (Satow et al., 2001). Hey proteins are expressed
at high levels in the developingDRGand trigeminal ganglia (Leimeister
et al., 1999, 2000; Nakagawa et al., 1999) but their roles in sensory
ganglion development and neuronal speciﬁcation are unknown.
Sensory ganglion neurons are divided into three major subpopula-
tions based on their expression of the neurotrophin receptors and the
type of sensory information they convey—TrkA+ which convey
information from thermoreceptors and nociceptors, TrkB+ that
convey mechanosensory information and TrkC+ that are propriocep-
tive (Snider, 1994). Here, we report that mice carrying a targeted
mutation in the HeyL gene have decreased numbers of large TrkC+
neurons in the DRG. Moreover, HeyL in the DRG inhibits Hey1
expression and mice mutant for Hey1 alone have increased numbers
of TrkC+ neurons in the DRG suggesting that Hey1 and HeyL play
antagonistic roles in TrkC+ neuron differentiation.
Materials and methods
Generation and maintenance of mouse lines
The targeting construct was generated from the BAC clone RP23-
25K8 (CHORI) containing the HeyL locus by recombineering as
previously described (Liu et al., 2003). All vectors and bacterial
strains used for creating the targeting vector were kind gifts from Dr.
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introduced such that they ﬂanked the exons 2–5 of the HeyL gene
and a neomycin resistance cassette (pGK-neo) ﬂanked by FRT sites
was introduced downstream of the HeyL gene (Fig. 1A). The targeted
regionwas ﬂanked both upstream and downstream by 3 kb homology
regions for recombination. The targeting construct was electroporated
into HM1 mouse ES cells and the neomycin resistant colonies were
screened by southern hybridization with a ∼700 bp probe down-
stream of the 3′ homology region. Targeted ES cells were used by the
Northwestern University Transgenic and Targeted Mutagenesis Facil-
ity to generate chimeras that transmitted the targeted (HeyLfn) allele
to their progeny. EIIa-cre mice (Jackson Labs) and ROSAFlp1/Flp1
(Jackson Labs) were bred to HeyLfn/+ and the progeny were
backcrossed to WT C57BL6 mice to generate HeyL+/− and HeyLfx/+
mice, respectively. Genotyping was done by polymerase chain
reaction (PCR) using a combination of four primers a-5′-GAGCTCTC-
TCATGCATGTTCTGCG-3′, b-5′-GGCTAGTTTCTCAGAGCTGAAGGATC-3′,
c-5′-CCCCCATACACACACCCTGTTATTCTAG-3′ and d-5′-GAAGCTCTA-
AGAGGAAATGCTGGGG-3′ as shown in Fig. 1C. The Hey1+/− mice
were kind gifts from Dr. Manfred Gessler and have been described
previously (Fischer et al., 2004). Hey1−/−; HeyL+/− and Hey1+/−;
HeyL−/− mice were bred to obtain the control (Hey1+/−; HeyL+/−),
Hey1 mutant (Hey1−/−; HeyL+/−), HeyL mutant (Hey1+/−; HeyL−/−)
and Hey1/L double mutant (Hey1−/−; HeyL−/−) mice.
Southern hybridization and quantitative real time PCR
Genomic DNA was extracted from ES cell colonies and 10 μg of
genomic DNA samples were digested overnight at 37 °C with BssSI
(New England Biolabs). The digested DNA was run on a 0.5% agarose
gel, denatured using a solution containing 1.5 M NaCl and 0.5 N NaOH
before being neutralized in 1M Tris (pH 7.4). The DNA fragments were
then transferred from the gel to a nitrocellulose membrane overnight
by capillary transfer. The membrane was baked at 80 °C for 2 h to ﬁx
the DNA on the ﬁlter. DIG labeled probe was generated from genomic
DNA by PCR using DIG DNA Labeling and Detection Kit (Roche) andFig. 1. Targeting and genotyping strategies for HeyL knock out mice. (A) Exons 2–5 of the Hey
sequences in the targeted HeyLfn allele after homologous recombination. A neomycin resistan
5. The targeted allele in the presence of germline ﬂpe or cre recombinases generated the HeyL
restriction digestionwith the 3′ probe in (A) detected a smaller 6.66 kb fragment showing th
between different alleles. Note the ∼2 kb band (arrow) for the HeyLfn allele when the genom
mRNA with GAPDH as internal control showed the lack of HeyL mRNA in HeyL−/−. B—BssShybridization and detection was done as per manufacturer's instruc-
tions. RNAwas extracted from the tissue using RNA Aqueous 4 PCR Kit
(Ambion) following manufacturer's instructions. cDNA was prepared
from the RNA samples with OligodT primers using Thermoscript RT
(Invitrogen) following manufacturer's instructions. Real time PCR was
done on a Mastercycler ep realplex system (Eppendorf) with SYBR
green (Applied Biosystems) PCR mix.
Immunohistochemistry
Mouse embryo, P0 mouse spinal columns with DRGs or P0 mouse
thoracic segment with DRGs and sympathetic ganglia were ﬁxed in 4%
paraformaldehyde for 2 h and cryoprotected in 30% sucrose solution
overnight. The dehydrated tissue samples were frozen in OCT (Tissue
Tek) before being cryosectioned on a CM3050S cryostat (Leica) at
10 μm thickness for immunohistochemistry. The tissue sections were
incubated with primary antibody overnight at 4 °C in a solution
containing 1% BSA, 0.25% Triton-X100 and 2% goat serum. For some
antibodies antigen retrieval was done by boiling the sections in 10mM
sodium citrate solution pH 6 for 10 min before incubation with
primary antibodies. After washes the tissue sections were incubated
with Alexa Fluor conjugated goat secondary antibodies (1:500)
(Invitrogen) in a solution containing 1% BSA, 0.25% Triton-X and
DAPI nuclear stain (Invitrogen) for 1 h before a second set of washes
and being mounted in ProLong Gold antifade reagent (Invitrogen).
The primary antibodies used were Rabbit anti-ER81 (1:1000;
Covance), Rabbit anti-p75 (1:500; Dr. Louis Reichardt), Rabbit anti-
Parvalbumin (1:1000; Swant), Rabbit anti-Sox10 (1:1000; Abcam),
Mouse anti-Substance P (1:500; R&D), Rabbit anti-TrkA (1:500; Dr.
Louis Reichardt), Goat anti-TrkB (1:100; R&D), Goat anti-TrkC (1:50;
R&D), and Mouse anti-Tyrosine hydroxylase (1:500; Sigma).
RNA in situ hybridization
Whole mount RNA in situ hybridization was done as described
previously (Avilion et al., 2000). For in situ hybridization on tissueL locus that code for the bHLH and orange domains were ﬂanked by loxP (red triangles)
ce cassette ﬂanked by FRT sequences (blue triangles) was also introduced 3′ of the exon
fx and HeyL− alleles respectively. (B) Southern hybridization of genomic DNA after BssSI
e presence of HeyLfn allele. (C) Genotyping primers a–d in (A) were used to distinguish
ic DNA is ampliﬁed with primers c and d. (D) Quantitative real time PCR from trigeminal
I, H—HinfI, B’—BslI.
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hyde ﬁxation and 30% sucrose cryoprotection. Plasmid vectors
containing cDNA for Hey1, Hey2 and HeyL were kind gifts from Dr.
Gessler and have been used previously to generate antisense RNA
probes (Leimeister et al., 1999, 2000). DIG labeled probes were
prepared from the cDNA by PCR using DIG RNA Labeling Kit (Roche) as
per manufacturer's instructions. The sections were hybridized in
hybridization solution (50% Formamide, 5× SSC, 1% SDS, 500 μg/ml
tRNA, 200 μg/ml acetylated BSA, 50 μg/ml heparin) overnight at 68 °C
after which three stringency washes were done for 45 min in a wash
solution (50% Formamide, 2× SSC, 1% SDS) at 68 °C. The DIG labeling
was detected using a peroxidase conjugated anti DIG antibody
(1:2500, Roche) and developed in NBT/BCIP solution (Roche).
Cell counts and statistical analysis
Sections from six different thoracic DRGs (T1–T6) per animal or
the adjacent sympathetic ganglia were immunostained and images
were taken using an Axiovert epiﬂuorescence microscope (Zeiss).
Cells were counted from four of the largest sections from each DRG,
trigeminal and sympathetic ganglia manually using NIH ImageJ
software. The area of each DRG, trigeminal and sympathetic ganglia
section was also measured using ImageJ and the average number of
cells per square millimeter (sq. mm) was calculated for each animal.
At least three animals of each genotype were used to get the average
number of cells per sq. mm. The examiner was not aware of the
genotypes of the specimens while acquiring images and counting the
cells. In experiments with only two conditions Student's t-test
assuming unequal variance was used while for multi condition
experiments one-way ANOVA followed by Tukey's post hoc text was
used to determine statistical signiﬁcance. All data is presented as
mean±SEM.Fig. 2. HeyL is expressed in migrating neural crest cells and is not required for their migration
strong expression in the trigeminal and DRG. (B, C) mRNA in situ hybridization for HeyL (B) an
tissue sections showed identical expression patterns in the DRGs and the spinal nerve roots
HeyL−/− (E) compared to WT controls (D). Scale bar, 100 μm.Results
Generation of HeyL mutant mice
To generate a HeyL mutant a targeting vector was constructed that
contained exons 2–5 of the HeyL locus ﬂanked by loxP sequences
(Fig. 1A). The targeting construct was introduced into mouse ES cells
and homologous recombination was identiﬁed by southern hybridi-
zation with a probe downstream of the targeted region of the HeyL
locus after BssSI digestion of the genomic DNA (Fig. 1B). ES cell lines
containing the targeted HeyL locus were used to generate chimeras
that transmitted the HeyLfn allele to their offspring. Mice carrying the
HeyLfn allele were crossed to mice constitutively expressing Flpe
recombinase (ROSA-Flpe) and cre recombinase (EIIa-cre) to generate
offspring that had the neomycin cassette excised (fx) and the HeyL
exons 2–5 excised (null) respectively (Fig. 1A). Genotyping primers a,
b, c and d in different combinations were used to assess recombina-
tion and to distinguish the HeyL WT, fn, fx and null alleles (Fig. 1C).
The HeyL transcript was detectable only at background levels in the
homozygous null mutant (HeyL−/−) trigeminal ganglion using quan-
titative RT-PCR (Fig. 1D).
The HeyL−/− animals were viable and were obtained at Mendelian
frequencies. Loss of HeyL did not cause any overt effect on the size or
weight of the animals and HeyL−/− mice survived to adulthood and
were fertile. Since, the HeyL−/− mice were viable, the HeyLfx/fx
animals were not used in the analysis and will not be discussed. Thus,
functional HeyL is not required for the postnatal survival in mice.
Expression of HeyL in the developing nervous system
In the developing mouse embryo HeyL is expressed in the
somites, peripheral nervous system, smooth muscle of all arteries. (A) Whole mount in situ hybridization for HeyLmRNA on an E10.5WT embryo showed
d immunohistochemistry for Sox10 (red) and nuclear stain DAPI (blue) (C) on adjacent
at E10.5. (D–F) There was no change in the number of Sox10+ cells in the DRGs of E11.5
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ister et al., 2000; Nakagawa et al., 1999). To investigate which cells in
developing peripheral ganglia express HeyL we performed RNA in
situ hybridization. In E10.5 embryos HeyL mRNA was expressed in
dorsal root, trigeminal, and sympathetic ganglia and their nerve
roots (Fig. 2A). This expression pattern was very similar to the
expression pattern of the SRY family transcription factor Sox10 that
is expressed in migrating neural crest progenitor cells (Britsch et al.,
2001; Kuhlbrodt et al., 1998). For closer examination we probed
DRGs from adjacent tissue sections for HeyL mRNA and Sox10
protein and found that the HeyL expression (Fig. 2B) was identical to
that of Sox10 (Fig. 2C) in the DRG suggesting they are coexpressed.
HeyL expression was also detected in the mesenchyme surrounding
the neural tube (Fig. 2B) as has been previously described
(Nakagawa et al., 1999).
Since, HeyL was expressed in migrating neural crest cells we
investigated if loss of HeyL function affected the neural crest
progenitor cell population in the embryonic DRG. Comparison of
E11.5 HeyL−/− DRGs with their wild type (WT) littermates did notFig. 3. Loss of HeyL leads to elevated expression of Hey paralogs in the DRG and trigeminal. (A
trigeminal ganglion (C) but not in the HeyL−/− DRG (B) or trigeminal (D). (E–H) Hey1 exp
ganglion (G) in the WT. There was an increased level of Hey1 expression in the DRG (F) but n
the boundary cap cells in theWT (I) and was unaffected in the HeyL−/− (J). Hey2was also de
seen in the trigeminal root of the HeyL−/−(L). Scale bar, 100 μm.show any change in the number of Sox10 expressing neural crest
progenitor cells (Figs. 2D–F). We also did not ﬁnd an increase in
cell death in the DRG at E11.5, as assessed by cleaved caspase3
immunohistochemistry, in the absence of HeyL (data not shown).
Together, these observations suggest that HeyL is expressed in
migrating neural crest progenitor cells but is not required for their
migration or survival.
Effects of loss of HeyL on Hey family paralogs
The Hey genes are all expressed in the peripheral nervous system
during development (Leimeister et al., 1999, 2000; Nakagawa et al.,
1999; Steidl et al., 2000). To examine the effects of loss of HeyL on
the expression pattern of the other family members we performed
in situ hybridization with probes for Hey1, Hey2 and HeyL mRNA
on DRG and trigeminal ganglia of HeyL−/− and WT littermates at
E11.5. As expected HeyL mRNA was not detected in the Hey−/− DRG
and trigeminal ganglia (Figs. 3B, D) but could be detected in the WT
(Figs. 3A, C).–D) HeyL expressionwas detected by in situ hybridization in the E11.5WT DRG (A) and
ression was detected in the WT DRG and spinal cord ﬂoor plate (E) and the trigeminal
ot in the trigeminal ganglion (G) in the HeyL−/−. (I–L) Hey2 expressionwas detected in
tected in the trigeminal ganglion in theWT (K) and an increased level of expressionwas
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regions where HeyLmRNAwas not detected (Figs. 3A, B), Hey1mRNA
expression was not affected in HeyL−/− compared to WT mice (Figs.
3E, F). However, in the DRG where Hey1 and HeyL are both expressed,
Hey1 mRNA was upregulated compared to the WT (Figs. 3E, F)
suggesting that HeyLmay inhibit the expression of Hey1 in the DRG. In
the trigeminal ganglion Hey1 transcript was detected only at low
levels in the WT (Fig. 3G) and the expression was not different in the
HeyL−/− mice (Fig. 3H). Interestingly, Hey2 mRNA was detected only
in the boundary cap cells (Fig. 3I) that give rise to glia in the spinal
nerve roots and some neurons and glia in the DRG (Maro et al., 2004).
Loss of HeyL however, did not affect the expression of Hey2 in the
boundary cap cells (Fig. 3J). In the trigeminal ganglia there was diffuse
expression of Hey2 both in the ganglion and the nerve root (Fig. 3K)
and the expression was upregulated in the nerve root in the HeyL−/−
mice (Fig. 3L) suggesting that HeyLmight be involved in the inhibition
ofHey2 in the trigeminal ganglion. Thus, loss of HeyL expression causes
an upregulation of Hey paralogs in regions of overlapping expression.
Role of HeyL in differentiation of sensory neurons in the DRG
Soon after neurogenesis begins in the DRG (E11.5) almost all DRG
neurons express TrkC and many co-express TrkA and TrkB. At this
stage neurotrophin receptor expression does not correspond to the
functional subtypes of the DRG neurons (White et al., 1996). Later in
development neurotrophin receptor expression becomes speciﬁc to
the subtype of DRG neuron with the majority expressing TrkA by
postnatal day 0 (P0) (Carroll et al., 1992; Mu et al., 1993). Since HeyL is
expressed at high levels during the neurogenic period in the DRG we
examined if HeyL has a role in the differentiation of different subtypes
of neurons.
We immunostained P0 thoracic DRGs with antibodies against
TrkA, TrkB, TrkC and the pan neuronal marker NeuN. The total
number of NeuN+ neurons in the HeyL−/− DRGs were comparable
to the WT littermates (Supplementary Figs. 1A, B, Fig. 4G). On
analyzing the speciﬁc subtypes, TrkA+ and TrkB+ neuronal popula-
tions in the HeyL−/− compared to WT DRG were similar in numbers
though the TrkB+ neurons showed a statistically insigniﬁcant
reduction (Figs. 4A–D and H, I). However, the large TrkC+ neurons
showed a signiﬁcant ∼19% reduction (260.6±7.5 cells/mm2 for WT
vs 210.4±11.4 for HeyL−/−; p-valueb0.05) in the HeyL−/− DRGs.
The TrkA+ neurons are distributed throughout the DRG, while
majority of the TrkB+ and TrkC+ neurons are usually found at the
periphery (Mu et al., 1993). There was no overall change in the
distribution of the TrkA+, TrkB+ or TrkC+ neurons in the DRG of the
HeyL−/− animal (Figs. 4A–E).
Another region of high HeyL expression is the developing
trigeminal ganglion (Fig. 2A). We also examined the neuronal
subtypes in trigeminal ganglia but did not ﬁnd any signiﬁcant changes
in the numbers of different sensory neuron subtypes (Supplementary
Figs. 1C–N). Hence, loss of HeyL caused a reduction in the number of
proprioceptive large TrkC+ neurons speciﬁcally in the DRG without
affecting the nociceptive and thermoceptive TrkA+ neurons or the
mechanosensory TrkB+ neuron numbers or their distribution.
Effects of loss of HeyL on subtypes of TrkC expressing neurons
Since only a small subpopulation of the TrkC+ neurons was lost in
the HeyL mutant we investigated the expression of proteins that
characterize different subsets of TrkC+ DRG neurons. The calcium
binding protein parvalbumin (PV) is expressed in a large subpopula-
tion of the proprioceptive neurons and is related to their functional
properties (Antal et al., 1990; Carr et al., 1989a,b; Ringstedt et al.,
1997). We immunostained thoracic DRGs from HeyL mutants and WT
mice and found a small decrease in the number of PV immunoreactive
cells in the mutant (Figs. 5A–C).A subset of TrkC+ muscle sensory afferent neurons expresses the
ETS gene ER81 (Lin et al., 1998). Mice carrying mutations in ER81
exhibit limb ataxia and abnormal ﬂexor–extensor posturing of their
limbs and proprioceptive Ia afferents are lost (Arber et al., 2000).
Since ER81 is expressed in DRG neurons outside the TrkC+ popula-
tion (Arber et al., 2000) we immunostained DRGs for both TrkC
and ER81 to examine effects on the ER81+ subpopulation.
Interestingly, the HeyL mutant DRGs exhibited a signiﬁcant ∼20%
reduction (90.4±6.4 cells/mm2 for WT vs 72.5±2.3 for HeyL−/−;
p-valueb0.05) in the number of ER81+/TrkC+ neurons compared
to the WT (Figs. 5D–F). This is similar to the reduction in the total
number of TrkC+ neurons in the DRG of HeyL mutants (Fig. 4J) and
suggests that both ER81+ and ER81− subpopulations of TrkC+
neurons are affected in the HeyL mutant. Together, these observa-
tions suggest a role for HeyL in the differentiation of multiple
subpopulations of TrkC+ neurons in the DRG.
Contrasting roles of Hey1 and HeyL in sensory neuron differentiation
Our previous results demonstrate an upregulation of Hey1
expression and a reduction in the TrkC+ neurons in the DRGs of the
HeyL−/− mice. This leads to two contrasting possibilities, either that
loss of HeyL expression causes a compensatory increase in the
expression of Hey1 that attenuated the reduction in TrkC+ neurons or
that HeyL inhibition of Hey1 is required for the differentiation of a
subpopulation of TrkC+ neurons. To investigate these possibilities we
generated mice carrying mutations in both Hey1 and HeyL and
examined neuronal differentiation in the thoracic DRGs. We hypothe-
sized that if the upregulation of Hey1 is compensatory in nature, Hey1
and HeyL should have similar roles in the differentiation process. Hey1
mutants (Hey1−/−; HeyL+/−) would then be expected to have a
reduction in the number of TrkC+ neurons, and there might be a more
pronounced effect on the differentiation of TrkC+ neurons in Hey1/L
double mutant (Hey1−/−; HeyL−/−) mice. Alternatively, if Hey1
repression by HeyL plays a role in the differentiation of TrkC+ neurons
in the DRG, then the Hey1 null mice should have an increased number
of TrkC+ neurons compared to the controls.
The total number of neurons in the DRGs of Hey1 mutant and
Hey1/2 double mutant mice assessed by NeuN immunostaining were
comparable to control DRGs (Figs. 6A–D). The TrkA+ and TrkB+
neuronal populations in the DRGs of Hey1 or Hey1/L double mutant
mice also did not show any changes compared to that in control DRGs
(Figs. 6E–L). Examination of other neuronal subtypes in the DRG
based on the expression of the peptide Substance P and the low
afﬁnity neurotrophin receptor p75 did not reveal any signiﬁcant
changes in the Hey1, HeyL or Hey1/L double mutants compared to the
control animals (Supplementary Figs. 2A–J). Surprisingly, however,
the number of TrkC+ neurons in the DRG of Hey1 mutants was
signiﬁcantly increased and there were no signiﬁcant changes in
the Hey1/L double (325.3±12.6 for Hey−/− vs 253.41±29.2 for
Hey1−/−; HeyL−/− vs 236.5±11.4 for Hey1+/−; HeyL+/−; p-
valueb0.05) mutants compared to the control DRGs (Figs. 6M–P).
These results together with the observed increase in Hey1 expression
in the HeyL−/− ganglia suggest that Hey1 and HeyL have antagonistic
roles in the differentiation of TrkC+ neurons in the DRG.
Discussion
We have created a mouse that carries mutation in the bHLH
transcription factor HeyL. The mutation in the HeyL locus deletes
sequences that code for all the conserved domains in the HeyL protein
including the bHLH, orange and the C-terminal TEIGAF and YHSW
motifs and presumably any function performed by the HeyL protein is
lost in the mutant animals. The growth, survival and fertility of the
mutant mice were not affected by the absence of HeyL function. The
only other reported HeyL mutation in mice in which only the bHLH
Fig. 4. Loss of HeyL reduces the number of TrkC expressing neurons in the DRG. (A–D) DRG neuronal populations inWT that immunostained for TrkA (green) (A) and TrkB (red) (C) were not affected by the loss of HeyL (B, D). (E, F) TrkC+ (red)
neurons were signiﬁcantly reduced in the HeyL−/− (F) compared to the WT (E). (G–J) Quantiﬁcation of the neurons (NeuN) (G), TrkA (H), TrkB (I) and TrkC (J) in WT and HeyL−/−. ⁎pb0.05 by Student's t-test. Scale bar 100 μm.
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Fig. 5.Mutation in HeyL reduces the ER81 expressing subpopulation of TrkC+ neurons. (A–C) The PV+ (green) subpopulation of TrkC+ neurons showed a reduction in the HeyL−/−
that is not statistically signiﬁcant (C). (D–F) The TrkC+ (red) neurons in the DRG that expressed ER81 (green) showed a signiﬁcant reduction in the HeyL−/− (E, F) compared to the
WT (D). ⁎pb0.05 by Student's t-test Scale bar, 100 μm.
148 A. Mukhopadhyay et al. / Developmental Biology 334 (2009) 142–151and orange domains were affected (Fischer et al., 2007) also did not
affect survival. Thus, the additional loss of the conserved C-terminal
motifs in the HeyL mutant reported here did not cause any differential
effect on survival.
Comparison of the expression of HeyL and Sox10 indicates that
HeyL is expressed by neural crest progenitor cells during the neu-
rogenic period in dorsal root, sympathetic and trigeminal ganglia.
Expression of HeyL in neural crest progenitors indicates two
contrasting possibilities for the role of HeyL. First, HeyL might be
required for the migration and maintenance of the neural crest
progenitor population. However the normal number of Sox10+ cells in
the DRG indicates that this is not the case. Alternatively, HeyL might
play a role in the differentiation of neural crest progenitors into
mature cell types. The reduction in the numbers of large TrkC+
neurons in the DRGs of HeyL null mice at P0 provides evidence for the
second possibility. The TrkB+ neuronal population also showed a
modest reduction in the in the HeyL mutants DRG that was not
statistically signiﬁcant. The loss of HeyL did not change the total
number of neurons in the DRG of the mutants though there was a
trend towards a reduction. However the TrkB+ and TrkC+ subpopula-
tions of neurons in the DRG together constitute less than 20% of the
total neurons (Mu et al., 1993). Thus the changes in the size of these
small populations in the HeyL mutant might not be sufﬁcient to
detectably change total neuron numbers given the threshold of
detection using cell counting methods. The neurons of the sympa-
thetic ganglia, which are derived from the neural crest cells and also
expressed HeyL, were not signiﬁcantly affected in the HeyL mutant
mice as assessed by tyrosine hydroxylase immunostaining (Supple-
mentary Figs. 2K–O). Other mature cell types arising from Sox10+
neural crest cells include Schwann cells and satellite glia in the PNS
(Britsch et al., 2001). We did not ﬁnd any gross changes in Schwann
cell differentiation after loss of HeyL, but we cannot exclude the
possibility of subtle molecular changes in Schwann cells that might
indirectly affect the differentiation of DRG neurons.We ﬁnd that a null mutation in HeyL increases levels of Hey1 in
the DRG and Hey2 in the trigeminal ganglion. Analogy to the Hes
family of factors suggests that HeyL directly represses expression of
Hey1 and Hey2 by binding to their promoters. In fact direct
repression by HeyL of in vitro reporter expression from the Hey2
promoter has been reported (Nakagawa et al., 2000) and our results
provide the ﬁrst evidence of this mechanism in vivo. HeyL shows a
weaker response to Notch signaling than Hey1 or Hey2 (Maier and
Gessler, 2000; Nakagawa et al., 2000). This suggests that HeyL may
also be regulated by other signaling molecules and indeed HeyL
expression is upregulated in neural progenitor cells exposed to
bone morphogenetic protein4 (BMP4) (Jalali et al., unpublished).
Interestingly, expression of Hey1 can be synergistically induced in
the presence of Notch and BMP signaling in endothelial cells (Itoh
et al., 2004). BMP signaling regulates the expression of TrkC in
neurons in the PNS (Chalazonitis, 2004; Chalazonitis et al., 2004;
Zhang et al., 1998). The reduction in TrkC+ neurons in the DRG
when HeyL function is lost suggests that HeyL might be an
effecter of BMP mediated TrkC expression in a subset of TrkC+
neurons.
The Runt family transcription factor Runx3 is expressed in TrkC+
neurons and has been implicated in the cell fate speciﬁcation in the
DRG and projection of sensory afferents (Inoue et al., 2007, 2002;
Kramer et al., 2006; Levanon et al., 2002). However Runx3 does not
mediate the expression of TrkC in response to BMPs (Inoue et al.,
2007). Recently, it has been shown that there is a late born
subpopulation of DRG neurons that expresses TrkC independent of
Runx3 and that does not express PV (Nakamura et al., 2008). However
the HeyL mutant does not exhibit a signiﬁcant reduction in PV+
neurons indicating the reduction in TrkC+ neurons is predominantly
from the TrkC+/PV− subpopulation. In addition, the HeyL mutant has
similar numbers of TrkC+ neurons in the DRG at an earlier time point
E11.5 (data not shown) and does not exhibit limb ataxia like the Runx3
mutant (Inoue et al., 2002; Levanon et al., 2002). This suggests that
Fig. 6. Loss of Hey1 increases the number of TrkC expressing neurons in the DRG. (A–C) Thoracic DRGs immunostained for NeuN (blue), TrkA (green) (E–G), TrkB (red) (I–K) and TrkC
(red) (M–O) in the Hey1 mutant (Hey1−/−; HeyL+/−) (B, F, J, N), Hey1/L double mutants (Hey1−/−; HeyL−/−) (C, G, K, O) and control (Hey1+/−; HeyL+/−) littermates (A, E, I, M).
Note that the TrkC+ subpopulation in the Hey1 mutants (N) is increased and in double mutants (O) it is comparable to that of the control (M) at P0. (D, H, L, P) Quantiﬁcation of the
neurons (NeuN) (D), TrkA (H), TrkB (L) and TrkC (P) immunoreactive cells in the control, Hey1 mutant and Hey1/L double mutant DRGs. ⁎pb0.05 by ANOVA. Scale bar, 100 μm.
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pendent subpopulation of TrkC+ neurons.
The neuronal subtypes in the trigeminal ganglion assessed by the
expression of different Trk receptors were not affected in the HeyL
mutant. The POU domain transcription factor Brn-3a has been
implicated in playing a role in the expression of Trk receptors in the
trigeminal ganglia (Huang et al., 1999; McEvilly et al., 1996; Xiang
et al., 1996). In Brn-3a mutant mice Trk receptor expression and
neuronal numbers are reduced in the trigeminal but remain
unaffected in the DRGs (Huang et al., 1999; Xiang et al., 1996).
Interestingly, though TrkC expression is almost absent in the
trigeminal ganglion of the Brn-3a mutants, PV expression appears
normal (Huang et al., 1999). The maintenance of PV expressionwith a
reduction in TrkC expression in Brn-3a mutant trigeminal is similar to
what we observe in the DRG in HeyL mutants. Hence, both Brn-3a and
HeyL may function in a similar manner downstream of signals that
regulate the expression of TrkC in the sensory neurons in the
trigeminal and DRG respectively.In the cardiovascular development, Hey2 plays the crucial role
with loss of Hey2 alone causing developmental defects (Donovan et
al., 2002; Gessler et al., 2002; Kokubo et al., 2004; Sakata et al., 2002)
and the HeyL and Hey1 single mutant mice appear normal (Fischer et
al., 2004, 2007). There is functional redundancy between Hey1 and
HeyL as the Hey1/L double mutant exhibits cardiac defects and
partial perinatal lethality (Fischer et al., 2007). In contrast, our
results suggest, Hey1 and HeyL play opposing roles in the
differentiation of TrkC+ neurons in the DRG. Moreover, overexpres-
sion of HeyL in neural progenitors causes neuronal differentiation
(Jalali et al., unpublished) which is antagonistic to that of the known
proglial function of Hey1 and Hey2 in the nervous system (Sakamoto
et al., 2003; Satow et al., 2001). The functional differences can be
attributed partly to the structural differences between HeyL and
other Hey proteins. Structurally, HeyL diverges further from the other
two Hey proteins in both the orange domain and the YXPW motif
(Leimeister et al., 1999; Nakagawa et al., 1999; Steidl et al., 2000).
Furthermore, unlike the YHSW motif present in HeyL, the YRPW and
150 A. Mukhopadhyay et al. / Developmental Biology 334 (2009) 142–151YQPW motifs present in Hey1 and Hey2, respectively, are structurally
closer to the classical groucho binding WRPW domain present in Hes
proteins. Hes6 which belongs to the closely related Hes family of
proteins also diverges in function from other Hes proteins like Hes1,
Hes3 or Hes5 in the nervous system (Bae et al., 2000; Koyano-
Nakagawa et al., 2000) whereas Hes6 functions similarly to other Hes
proteins in non-neural tissues (Cossins et al., 2002). The difference in
the functions of Hes6 and other Hes proteins is partly due to a
shorter loop in the bHLH sequence (Bae et al., 2000; Koyano-
Nakagawa et al., 2000; Pissarra et al., 2000; Vasiliauskas and Stern,
2000). Thus, the divergent structure and function of HeyL in the
peripheral nervous system are similar to those of Hes6 in the central
nervous system.
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